Learn more

MCSWIGGEN JAMES

Overview
  • Total Patents
    33
About

MCSWIGGEN JAMES has a total of 33 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are RXI PHARMACEUTICALS CORP, ALNYLAM EUROPE AG and ARCHEMIX CORP.

Patent filings in countries

World map showing MCSWIGGEN JAMESs patent filings in countries
# Country Total Patents
#1 United States 18
#2 WIPO (World Intellectual Property Organization) 15

Patent filings per year

Chart showing MCSWIGGEN JAMESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mcswiggen James 33
#2 Beigelman Leonid 16
#3 Usman Nassim 6
#4 Polisky Barry 4
#5 Richards Ivan 3
#6 Pavco Pamela 2
#7 Beigleman Leonid 2
#8 Vargeese Chandra 2
#9 Vaish Narendra 1
#10 Vaish Narendra K 1

Latest patents

Publication Filing date Title
WO2009055445A2 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US2009281164A1 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
US2009137512A1 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
US2009023675A1 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
WO2007120527A2 Rna interference mediated inhibition of respiratory syncytial virus (rsv) expression using short interfering nucleic acid (sina)
WO2007084865A2 RNA INTERFERENCE MEDIATED INHIBITION OF B7-H1 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2005040379A2 RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2005045038A2 RNA interference mediated inhibition of GPRA and AAA1 gene expression using short nucleic acid (siNA)
WO2005045039A2 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2005035759A2 RNA INTERFERENCE MEDIATED INHIBITION OF HYPOXIA INDUCIBLE FACTOR 1 (HIF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2005045032A2 RNA INTERFERENCE MEDIATED INHIBITION OF EARLY GROWTH RESPONSE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2005007855A2 RNA INTERFERENCE MEDIATED INHIBITION OF B7-H1 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2005007859A2 Rna interference mediated inhibition of acetyl-coa carboxylase gene expression using short interfering nucleic acid (sina)
US2009137500A1 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
US2007203333A1 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US2008032942A1 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
US8202979B2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
WO02097114A2 Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv